Morgan Stanley Raises Price Target for Teradyne, Inc.
On April 30, Morgan Stanley analyst Shane Brett raised its price target for Teradyne (NASDAQ:TER) to $387 from $376 while maintaining an 'Equal Weight' rating. The firm cited higher estimates but noted a need to temper bullish expectations due to slower sequential revenue growth.
Topics: analyst rating Morgan Stanley price target increase Teradyne, Inc.